nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP2C19—Ifosfamide—germ cell cancer	0.0573	0.421	CbGbCtD
Atomoxetine—HTR1D—meninx—germ cell cancer	0.0414	0.0732	CbGeAlD
Atomoxetine—HTR1B—dura mater—germ cell cancer	0.0393	0.0696	CbGeAlD
Atomoxetine—HTR1D—dura mater—germ cell cancer	0.0381	0.0674	CbGeAlD
Atomoxetine—HTR2C—choroid plexus—germ cell cancer	0.0321	0.0567	CbGeAlD
Atomoxetine—CYP3A4—Ifosfamide—germ cell cancer	0.0277	0.204	CbGbCtD
Atomoxetine—CYP2D6—Vinblastine—germ cell cancer	0.0231	0.17	CbGbCtD
Atomoxetine—HTR2A—phrenic nerve—germ cell cancer	0.0222	0.0394	CbGeAlD
Atomoxetine—HTR1B—trigeminal nerve—germ cell cancer	0.0169	0.0299	CbGeAlD
Atomoxetine—HTR1D—trigeminal nerve—germ cell cancer	0.0164	0.029	CbGeAlD
Atomoxetine—HTR2A—choroid plexus—germ cell cancer	0.0161	0.0285	CbGeAlD
Atomoxetine—CYP3A4—Vinblastine—germ cell cancer	0.0147	0.108	CbGbCtD
Atomoxetine—CYP3A4—Etoposide—germ cell cancer	0.0132	0.0973	CbGbCtD
Atomoxetine—HTR1B—cranial nerve—germ cell cancer	0.012	0.0213	CbGeAlD
Atomoxetine—HTR1D—cranial nerve—germ cell cancer	0.0117	0.0206	CbGeAlD
Atomoxetine—HTR2A—myenteric nerve plexus—germ cell cancer	0.0114	0.0202	CbGeAlD
Atomoxetine—HTR6—ganglion—germ cell cancer	0.0101	0.0179	CbGeAlD
Atomoxetine—HTR1B—telencephalic ventricle—germ cell cancer	0.00979	0.0173	CbGeAlD
Atomoxetine—SLC6A3—telencephalic ventricle—germ cell cancer	0.00971	0.0172	CbGeAlD
Atomoxetine—HTR1D—telencephalic ventricle—germ cell cancer	0.00948	0.0168	CbGeAlD
Atomoxetine—HTR2C—telencephalic ventricle—germ cell cancer	0.00939	0.0166	CbGeAlD
Atomoxetine—HTR2A—trigeminal nerve—germ cell cancer	0.00813	0.0144	CbGeAlD
Atomoxetine—HTR2A—vagus nerve—germ cell cancer	0.0076	0.0135	CbGeAlD
Atomoxetine—CYP2C19—urine—germ cell cancer	0.00674	0.0119	CbGeAlD
Atomoxetine—HTR1B—ganglion—germ cell cancer	0.0061	0.0108	CbGeAlD
Atomoxetine—SLC6A3—ganglion—germ cell cancer	0.00605	0.0107	CbGeAlD
Atomoxetine—HTR1D—ganglion—germ cell cancer	0.0059	0.0105	CbGeAlD
Atomoxetine—HTR2C—ganglion—germ cell cancer	0.00585	0.0103	CbGeAlD
Atomoxetine—HTR2A—cranial nerve—germ cell cancer	0.00579	0.0103	CbGeAlD
Atomoxetine—HTR2A—pons—germ cell cancer	0.00572	0.0101	CbGeAlD
Atomoxetine—NPY1R—telencephalon—germ cell cancer	0.00554	0.00982	CbGeAlD
Atomoxetine—SLC6A4—ganglion—germ cell cancer	0.00554	0.00981	CbGeAlD
Atomoxetine—SLC6A2—ganglion—germ cell cancer	0.00488	0.00864	CbGeAlD
Atomoxetine—HTR1B—blood vessel—germ cell cancer	0.00485	0.00858	CbGeAlD
Atomoxetine—HTR2A—telencephalic ventricle—germ cell cancer	0.00471	0.00834	CbGeAlD
Atomoxetine—HTR1D—blood vessel—germ cell cancer	0.00469	0.00831	CbGeAlD
Atomoxetine—NPY1R—gonad—germ cell cancer	0.00463	0.00819	CbGeAlD
Atomoxetine—NPY1R—pituitary gland—germ cell cancer	0.00451	0.00799	CbGeAlD
Atomoxetine—HTR2A—urine—germ cell cancer	0.0043	0.00762	CbGeAlD
Atomoxetine—HTR2A—appendage—germ cell cancer	0.00419	0.00742	CbGeAlD
Atomoxetine—HTR2A—pineal body—germ cell cancer	0.00409	0.00724	CbGeAlD
Atomoxetine—NPY1R—adrenal gland—germ cell cancer	0.00403	0.00714	CbGeAlD
Atomoxetine—CYP3A4—urine—germ cell cancer	0.00398	0.00705	CbGeAlD
Atomoxetine—CYP2D6—urine—germ cell cancer	0.00392	0.00694	CbGeAlD
Atomoxetine—HTR6—telencephalon—germ cell cancer	0.0039	0.00691	CbGeAlD
Atomoxetine—NPY1R—endocrine gland—germ cell cancer	0.0035	0.00619	CbGeAlD
Atomoxetine—NPY1R—head—germ cell cancer	0.00345	0.00611	CbGeAlD
Atomoxetine—NPY1R—testis—germ cell cancer	0.00333	0.0059	CbGeAlD
Atomoxetine—HTR1B—trigeminal ganglion—germ cell cancer	0.00299	0.0053	CbGeAlD
Atomoxetine—HTR2A—ganglion—germ cell cancer	0.00293	0.00519	CbGeAlD
Atomoxetine—HTR1D—trigeminal ganglion—germ cell cancer	0.0029	0.00513	CbGeAlD
Atomoxetine—HTR1B—brainstem—germ cell cancer	0.00265	0.00469	CbGeAlD
Atomoxetine—SLC6A3—brainstem—germ cell cancer	0.00263	0.00465	CbGeAlD
Atomoxetine—HTR1D—brainstem—germ cell cancer	0.00257	0.00454	CbGeAlD
Atomoxetine—HTR2C—brainstem—germ cell cancer	0.00254	0.0045	CbGeAlD
Atomoxetine—HTR2A—endothelium—germ cell cancer	0.00253	0.00448	CbGeAlD
Atomoxetine—NPY1R—brain—germ cell cancer	0.0025	0.00443	CbGeAlD
Atomoxetine—HTR1D—eye—germ cell cancer	0.0025	0.00442	CbGeAlD
Atomoxetine—HTR6—head—germ cell cancer	0.00243	0.0043	CbGeAlD
Atomoxetine—NPY1R—lymph node—germ cell cancer	0.00242	0.00428	CbGeAlD
Atomoxetine—SLC6A4—brainstem—germ cell cancer	0.00241	0.00426	CbGeAlD
Atomoxetine—HTR1B—telencephalon—germ cell cancer	0.00235	0.00416	CbGeAlD
Atomoxetine—SLC6A3—telencephalon—germ cell cancer	0.00233	0.00413	CbGeAlD
Atomoxetine—HTR2A—blood vessel—germ cell cancer	0.00233	0.00413	CbGeAlD
Atomoxetine—HTR1D—telencephalon—germ cell cancer	0.00228	0.00403	CbGeAlD
Atomoxetine—HTR2C—telencephalon—germ cell cancer	0.00225	0.00399	CbGeAlD
Atomoxetine—SLC6A4—telencephalon—germ cell cancer	0.00214	0.00378	CbGeAlD
Atomoxetine—SLC6A2—brainstem—germ cell cancer	0.00212	0.00375	CbGeAlD
Atomoxetine—Phenoxybenzamine—SLC22A3—germ cell cancer	0.00195	0.572	CrCbGaD
Atomoxetine—SLC6A2—telencephalon—germ cell cancer	0.00188	0.00333	CbGeAlD
Atomoxetine—SLC6A2—decidua—germ cell cancer	0.00178	0.00316	CbGeAlD
Atomoxetine—HTR2C—medulla oblongata—germ cell cancer	0.00177	0.00314	CbGeAlD
Atomoxetine—HTR6—brain—germ cell cancer	0.00176	0.00312	CbGeAlD
Atomoxetine—Hypoaesthesia—Bleomycin—germ cell cancer	0.0017	0.00576	CcSEcCtD
Atomoxetine—HTR1B—midbrain—germ cell cancer	0.00169	0.00299	CbGeAlD
Atomoxetine—Pollakiuria—Ifosfamide—germ cell cancer	0.00169	0.00571	CcSEcCtD
Atomoxetine—SLC6A3—midbrain—germ cell cancer	0.00168	0.00297	CbGeAlD
Atomoxetine—HTR2A—neck—germ cell cancer	0.00167	0.00295	CbGeAlD
Atomoxetine—HTR1B—spinal cord—germ cell cancer	0.00165	0.00292	CbGeAlD
Atomoxetine—Breast disorder—Cisplatin—germ cell cancer	0.00165	0.00557	CcSEcCtD
Atomoxetine—HTR1D—midbrain—germ cell cancer	0.00164	0.0029	CbGeAlD
Atomoxetine—SLC6A3—spinal cord—germ cell cancer	0.00163	0.00289	CbGeAlD
Atomoxetine—Nasopharyngitis—Cisplatin—germ cell cancer	0.00163	0.00551	CcSEcCtD
Atomoxetine—Infestation—Ifosfamide—germ cell cancer	0.00163	0.00551	CcSEcCtD
Atomoxetine—Infestation NOS—Ifosfamide—germ cell cancer	0.00163	0.00551	CcSEcCtD
Atomoxetine—HTR2C—midbrain—germ cell cancer	0.00162	0.00287	CbGeAlD
Atomoxetine—Flushing—Bleomycin—germ cell cancer	0.00159	0.00537	CcSEcCtD
Atomoxetine—Vertigo—Vinblastine—germ cell cancer	0.00158	0.00536	CcSEcCtD
Atomoxetine—Conjunctivitis—Ifosfamide—germ cell cancer	0.00158	0.00536	CcSEcCtD
Atomoxetine—HTR2C—spinal cord—germ cell cancer	0.00158	0.0028	CbGeAlD
Atomoxetine—SLC6A2—gonad—germ cell cancer	0.00157	0.00278	CbGeAlD
Atomoxetine—Chills—Bleomycin—germ cell cancer	0.00154	0.00519	CcSEcCtD
Atomoxetine—SLC6A4—midbrain—germ cell cancer	0.00154	0.00272	CbGeAlD
Atomoxetine—Sweating increased—Cisplatin—germ cell cancer	0.00153	0.00519	CcSEcCtD
Atomoxetine—Convulsion—Vinblastine—germ cell cancer	0.00153	0.00517	CcSEcCtD
Atomoxetine—Bone disorder—Methotrexate—germ cell cancer	0.00153	0.00516	CcSEcCtD
Atomoxetine—Abdominal discomfort—Cisplatin—germ cell cancer	0.00151	0.00511	CcSEcCtD
Atomoxetine—SLC6A4—spinal cord—germ cell cancer	0.0015	0.00265	CbGeAlD
Atomoxetine—HTR1B—endocrine gland—germ cell cancer	0.00148	0.00263	CbGeAlD
Atomoxetine—Flushing—Dactinomycin—germ cell cancer	0.00148	0.00501	CcSEcCtD
Atomoxetine—SLC6A2—medulla oblongata—germ cell cancer	0.00148	0.00262	CbGeAlD
Atomoxetine—HTR1B—head—germ cell cancer	0.00146	0.00259	CbGeAlD
Atomoxetine—Hallucination—Ifosfamide—germ cell cancer	0.00146	0.00492	CcSEcCtD
Atomoxetine—Desipramine—SLC22A3—germ cell cancer	0.00145	0.427	CrCbGaD
Atomoxetine—SLC6A3—head—germ cell cancer	0.00145	0.00257	CbGeAlD
Atomoxetine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00144	0.00489	CcSEcCtD
Atomoxetine—Urethral disorder—Ifosfamide—germ cell cancer	0.00143	0.00485	CcSEcCtD
Atomoxetine—Chills—Dactinomycin—germ cell cancer	0.00143	0.00484	CcSEcCtD
Atomoxetine—HTR1D—head—germ cell cancer	0.00142	0.00251	CbGeAlD
Atomoxetine—Sweating increased—Etoposide—germ cell cancer	0.00141	0.00475	CcSEcCtD
Atomoxetine—HTR2C—head—germ cell cancer	0.0014	0.00249	CbGeAlD
Atomoxetine—SLC6A3—testis—germ cell cancer	0.0014	0.00248	CbGeAlD
Atomoxetine—HTR2A—embryo—germ cell cancer	0.00139	0.00246	CbGeAlD
Atomoxetine—Anorexia—Vinblastine—germ cell cancer	0.00137	0.00464	CcSEcCtD
Atomoxetine—SLC6A2—adrenal gland—germ cell cancer	0.00137	0.00242	CbGeAlD
Atomoxetine—Conjunctivitis—Cisplatin—germ cell cancer	0.00137	0.00462	CcSEcCtD
Atomoxetine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00136	0.00459	CcSEcCtD
Atomoxetine—Flushing—Ifosfamide—germ cell cancer	0.00136	0.00459	CcSEcCtD
Atomoxetine—SLC6A4—endocrine gland—germ cell cancer	0.00135	0.00239	CbGeAlD
Atomoxetine—SLC6A4—head—germ cell cancer	0.00133	0.00236	CbGeAlD
Atomoxetine—Angiopathy—Ifosfamide—germ cell cancer	0.00133	0.00449	CcSEcCtD
Atomoxetine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00132	0.00446	CcSEcCtD
Atomoxetine—Chills—Ifosfamide—germ cell cancer	0.00131	0.00444	CcSEcCtD
Atomoxetine—Cough—Bleomycin—germ cell cancer	0.0013	0.0044	CcSEcCtD
Atomoxetine—SLC6A3—cerebellum—germ cell cancer	0.0013	0.00229	CbGeAlD
Atomoxetine—Paraesthesia—Vinblastine—germ cell cancer	0.00129	0.00437	CcSEcCtD
Atomoxetine—Infestation—Etoposide—germ cell cancer	0.00129	0.00435	CcSEcCtD
Atomoxetine—Infestation NOS—Etoposide—germ cell cancer	0.00129	0.00435	CcSEcCtD
Atomoxetine—Mental disorder—Ifosfamide—germ cell cancer	0.00128	0.00433	CcSEcCtD
Atomoxetine—HTR2A—brainstem—germ cell cancer	0.00127	0.00226	CbGeAlD
Atomoxetine—Malnutrition—Ifosfamide—germ cell cancer	0.00127	0.00431	CcSEcCtD
Atomoxetine—Myalgia—Bleomycin—germ cell cancer	0.00127	0.00429	CcSEcCtD
Atomoxetine—Chest pain—Bleomycin—germ cell cancer	0.00127	0.00429	CcSEcCtD
Atomoxetine—Coma—Methotrexate—germ cell cancer	0.00126	0.00426	CcSEcCtD
Atomoxetine—Decreased appetite—Vinblastine—germ cell cancer	0.00125	0.00423	CcSEcCtD
Atomoxetine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00125	0.00421	CcSEcCtD
Atomoxetine—HTR2A—eye—germ cell cancer	0.00124	0.0022	CbGeAlD
Atomoxetine—Urethral disorder—Cisplatin—germ cell cancer	0.00124	0.00418	CcSEcCtD
Atomoxetine—Pain—Vinblastine—germ cell cancer	0.00123	0.00416	CcSEcCtD
Atomoxetine—Constipation—Vinblastine—germ cell cancer	0.00123	0.00416	CcSEcCtD
Atomoxetine—HTR2A—retina—germ cell cancer	0.00123	0.00218	CbGeAlD
Atomoxetine—Infection—Bleomycin—germ cell cancer	0.00121	0.00409	CcSEcCtD
Atomoxetine—Vision blurred—Ifosfamide—germ cell cancer	0.0012	0.00406	CcSEcCtD
Atomoxetine—SLC6A2—endocrine gland—germ cell cancer	0.00119	0.0021	CbGeAlD
Atomoxetine—Feeling abnormal—Vinblastine—germ cell cancer	0.00119	0.00401	CcSEcCtD
Atomoxetine—Myalgia—Dactinomycin—germ cell cancer	0.00118	0.004	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00118	0.00398	CcSEcCtD
Atomoxetine—SLC6A2—head—germ cell cancer	0.00117	0.00207	CbGeAlD
Atomoxetine—Cardiac disorder—Cisplatin—germ cell cancer	0.00117	0.00396	CcSEcCtD
Atomoxetine—Flushing—Cisplatin—germ cell cancer	0.00117	0.00396	CcSEcCtD
Atomoxetine—Agitation—Ifosfamide—germ cell cancer	0.00117	0.00396	CcSEcCtD
Atomoxetine—CYP2D6—brainstem—germ cell cancer	0.00116	0.00206	CbGeAlD
Atomoxetine—Anorexia—Bleomycin—germ cell cancer	0.00116	0.00392	CcSEcCtD
Atomoxetine—Hypoaesthesia—Etoposide—germ cell cancer	0.00115	0.00389	CcSEcCtD
Atomoxetine—Vertigo—Ifosfamide—germ cell cancer	0.00114	0.00387	CcSEcCtD
Atomoxetine—Urinary tract disorder—Etoposide—germ cell cancer	0.00114	0.00386	CcSEcCtD
Atomoxetine—Abdominal pain—Vinblastine—germ cell cancer	0.00114	0.00385	CcSEcCtD
Atomoxetine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00114	0.00384	CcSEcCtD
Atomoxetine—Urethral disorder—Etoposide—germ cell cancer	0.00113	0.00383	CcSEcCtD
Atomoxetine—SLC6A2—testis—germ cell cancer	0.00113	0.002	CbGeAlD
Atomoxetine—HTR2A—telencephalon—germ cell cancer	0.00113	0.002	CbGeAlD
Atomoxetine—Infection—Dactinomycin—germ cell cancer	0.00113	0.00381	CcSEcCtD
Atomoxetine—Palpitations—Ifosfamide—germ cell cancer	0.00113	0.00381	CcSEcCtD
Atomoxetine—CYP2C19—endocrine gland—germ cell cancer	0.00112	0.00198	CbGeAlD
Atomoxetine—Hepatic failure—Methotrexate—germ cell cancer	0.00111	0.00376	CcSEcCtD
Atomoxetine—Cough—Ifosfamide—germ cell cancer	0.00111	0.00376	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00111	0.00375	CcSEcCtD
Atomoxetine—Convulsion—Ifosfamide—germ cell cancer	0.0011	0.00373	CcSEcCtD
Atomoxetine—Malnutrition—Cisplatin—germ cell cancer	0.0011	0.00371	CcSEcCtD
Atomoxetine—Paraesthesia—Bleomycin—germ cell cancer	0.00109	0.00369	CcSEcCtD
Atomoxetine—Arthralgia—Ifosfamide—germ cell cancer	0.00108	0.00367	CcSEcCtD
Atomoxetine—Chest pain—Ifosfamide—germ cell cancer	0.00108	0.00367	CcSEcCtD
Atomoxetine—Myalgia—Ifosfamide—germ cell cancer	0.00108	0.00367	CcSEcCtD
Atomoxetine—Flatulence—Cisplatin—germ cell cancer	0.00108	0.00366	CcSEcCtD
Atomoxetine—Anorexia—Dactinomycin—germ cell cancer	0.00108	0.00366	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00108	0.00364	CcSEcCtD
Atomoxetine—Cardiac disorder—Etoposide—germ cell cancer	0.00107	0.00363	CcSEcCtD
Atomoxetine—Flushing—Etoposide—germ cell cancer	0.00107	0.00363	CcSEcCtD
Atomoxetine—HTR1B—brain—germ cell cancer	0.00106	0.00188	CbGeAlD
Atomoxetine—Decreased appetite—Bleomycin—germ cell cancer	0.00106	0.00357	CcSEcCtD
Atomoxetine—Muscle spasms—Cisplatin—germ cell cancer	0.00106	0.00357	CcSEcCtD
Atomoxetine—SLC6A3—brain—germ cell cancer	0.00105	0.00186	CbGeAlD
Atomoxetine—Angiopathy—Etoposide—germ cell cancer	0.00105	0.00354	CcSEcCtD
Atomoxetine—Mediastinal disorder—Etoposide—germ cell cancer	0.00104	0.00352	CcSEcCtD
Atomoxetine—Pain—Bleomycin—germ cell cancer	0.00104	0.00352	CcSEcCtD
Atomoxetine—Chills—Etoposide—germ cell cancer	0.00104	0.00351	CcSEcCtD
Atomoxetine—Vision blurred—Cisplatin—germ cell cancer	0.00103	0.0035	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00103	0.00349	CcSEcCtD
Atomoxetine—Asthenia—Vinblastine—germ cell cancer	0.00103	0.00349	CcSEcCtD
Atomoxetine—Infection—Ifosfamide—germ cell cancer	0.00103	0.00349	CcSEcCtD
Atomoxetine—CYP2D6—telencephalon—germ cell cancer	0.00103	0.00182	CbGeAlD
Atomoxetine—Tremor—Cisplatin—germ cell cancer	0.00103	0.00348	CcSEcCtD
Atomoxetine—HTR1D—brain—germ cell cancer	0.00103	0.00182	CbGeAlD
Atomoxetine—Lethargy—Methotrexate—germ cell cancer	0.00102	0.00345	CcSEcCtD
Atomoxetine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00102	0.00345	CcSEcCtD
Atomoxetine—HTR2C—brain—germ cell cancer	0.00102	0.0018	CbGeAlD
Atomoxetine—Skin disorder—Ifosfamide—germ cell cancer	0.00101	0.00341	CcSEcCtD
Atomoxetine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.001	0.0034	CcSEcCtD
Atomoxetine—Feeling abnormal—Bleomycin—germ cell cancer	0.001	0.00339	CcSEcCtD
Atomoxetine—Anorexia—Ifosfamide—germ cell cancer	0.00099	0.00335	CcSEcCtD
Atomoxetine—Decreased appetite—Dactinomycin—germ cell cancer	0.000986	0.00333	CcSEcCtD
Atomoxetine—Diarrhoea—Vinblastine—germ cell cancer	0.000985	0.00333	CcSEcCtD
Atomoxetine—Dysgeusia—Etoposide—germ cell cancer	0.000985	0.00333	CcSEcCtD
Atomoxetine—Fatigue—Dactinomycin—germ cell cancer	0.000978	0.00331	CcSEcCtD
Atomoxetine—Back pain—Etoposide—germ cell cancer	0.000973	0.00329	CcSEcCtD
Atomoxetine—Pain—Dactinomycin—germ cell cancer	0.00097	0.00328	CcSEcCtD
Atomoxetine—Muscle spasms—Etoposide—germ cell cancer	0.000967	0.00327	CcSEcCtD
Atomoxetine—Urticaria—Bleomycin—germ cell cancer	0.000966	0.00327	CcSEcCtD
Atomoxetine—SLC6A4—brain—germ cell cancer	0.000965	0.00171	CbGeAlD
Atomoxetine—Body temperature increased—Bleomycin—germ cell cancer	0.000961	0.00325	CcSEcCtD
Atomoxetine—Irritability—Methotrexate—germ cell cancer	0.000955	0.00323	CcSEcCtD
Atomoxetine—Dizziness—Vinblastine—germ cell cancer	0.000952	0.00322	CcSEcCtD
Atomoxetine—Convulsion—Cisplatin—germ cell cancer	0.000951	0.00322	CcSEcCtD
Atomoxetine—Mood swings—Methotrexate—germ cell cancer	0.000947	0.0032	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000947	0.0032	CcSEcCtD
Atomoxetine—HTR2A—gonad—germ cell cancer	0.000944	0.00167	CbGeAlD
Atomoxetine—Myalgia—Cisplatin—germ cell cancer	0.000934	0.00316	CcSEcCtD
Atomoxetine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000934	0.00316	CcSEcCtD
Atomoxetine—Paraesthesia—Ifosfamide—germ cell cancer	0.000933	0.00316	CcSEcCtD
Atomoxetine—Anxiety—Cisplatin—germ cell cancer	0.000931	0.00315	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000928	0.00314	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000927	0.00314	CcSEcCtD
Atomoxetine—Somnolence—Ifosfamide—germ cell cancer	0.000924	0.00312	CcSEcCtD
Atomoxetine—HTR2A—pituitary gland—germ cell cancer	0.000921	0.00163	CbGeAlD
Atomoxetine—Vomiting—Vinblastine—germ cell cancer	0.000915	0.0031	CcSEcCtD
Atomoxetine—Breast disorder—Methotrexate—germ cell cancer	0.000904	0.00306	CcSEcCtD
Atomoxetine—Vertigo—Etoposide—germ cell cancer	0.000903	0.00306	CcSEcCtD
Atomoxetine—Decreased appetite—Ifosfamide—germ cell cancer	0.000903	0.00306	CcSEcCtD
Atomoxetine—Headache—Vinblastine—germ cell cancer	0.000902	0.00305	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000897	0.00303	CcSEcCtD
Atomoxetine—Abdominal pain—Dactinomycin—germ cell cancer	0.000896	0.00303	CcSEcCtD
Atomoxetine—Body temperature increased—Dactinomycin—germ cell cancer	0.000896	0.00303	CcSEcCtD
Atomoxetine—Fatigue—Ifosfamide—germ cell cancer	0.000896	0.00303	CcSEcCtD
Atomoxetine—Infection—Cisplatin—germ cell cancer	0.00089	0.00301	CcSEcCtD
Atomoxetine—HTR2A—medulla oblongata—germ cell cancer	0.000889	0.00157	CbGeAlD
Atomoxetine—Pain—Ifosfamide—germ cell cancer	0.000889	0.00301	CcSEcCtD
Atomoxetine—Constipation—Ifosfamide—germ cell cancer	0.000889	0.00301	CcSEcCtD
Atomoxetine—Loss of consciousness—Etoposide—germ cell cancer	0.000884	0.00299	CcSEcCtD
Atomoxetine—Nervous system disorder—Cisplatin—germ cell cancer	0.000878	0.00297	CcSEcCtD
Atomoxetine—Cough—Etoposide—germ cell cancer	0.000877	0.00297	CcSEcCtD
Atomoxetine—Tachycardia—Cisplatin—germ cell cancer	0.000874	0.00296	CcSEcCtD
Atomoxetine—Asthenia—Bleomycin—germ cell cancer	0.000872	0.00295	CcSEcCtD
Atomoxetine—Convulsion—Etoposide—germ cell cancer	0.000871	0.00295	CcSEcCtD
Atomoxetine—Skin disorder—Cisplatin—germ cell cancer	0.00087	0.00294	CcSEcCtD
Atomoxetine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000866	0.00293	CcSEcCtD
Atomoxetine—Pruritus—Bleomycin—germ cell cancer	0.00086	0.00291	CcSEcCtD
Atomoxetine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000856	0.0029	CcSEcCtD
Atomoxetine—Chest pain—Etoposide—germ cell cancer	0.000856	0.0029	CcSEcCtD
Atomoxetine—Nausea—Vinblastine—germ cell cancer	0.000855	0.00289	CcSEcCtD
Atomoxetine—Anorexia—Cisplatin—germ cell cancer	0.000854	0.00289	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00085	0.00288	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00085	0.00287	CcSEcCtD
Atomoxetine—SLC6A2—brain—germ cell cancer	0.000849	0.0015	CbGeAlD
Atomoxetine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000829	0.0028	CcSEcCtD
Atomoxetine—Urticaria—Ifosfamide—germ cell cancer	0.000825	0.00279	CcSEcCtD
Atomoxetine—HTR2A—adrenal gland—germ cell cancer	0.000823	0.00146	CbGeAlD
Atomoxetine—Body temperature increased—Ifosfamide—germ cell cancer	0.000821	0.00278	CcSEcCtD
Atomoxetine—Abdominal pain—Ifosfamide—germ cell cancer	0.000821	0.00278	CcSEcCtD
Atomoxetine—SLC6A2—lymph node—germ cell cancer	0.000821	0.00145	CbGeAlD
Atomoxetine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000816	0.00276	CcSEcCtD
Atomoxetine—Infection—Etoposide—germ cell cancer	0.000815	0.00276	CcSEcCtD
Atomoxetine—Asthenia—Dactinomycin—germ cell cancer	0.000814	0.00275	CcSEcCtD
Atomoxetine—HTR2A—midbrain—germ cell cancer	0.000812	0.00144	CbGeAlD
Atomoxetine—Dysuria—Methotrexate—germ cell cancer	0.000808	0.00273	CcSEcCtD
Atomoxetine—Paraesthesia—Cisplatin—germ cell cancer	0.000804	0.00272	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000803	0.00272	CcSEcCtD
Atomoxetine—Tachycardia—Etoposide—germ cell cancer	0.000801	0.00271	CcSEcCtD
Atomoxetine—Skin disorder—Etoposide—germ cell cancer	0.000797	0.0027	CcSEcCtD
Atomoxetine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000796	0.00269	CcSEcCtD
Atomoxetine—Hyperhidrosis—Etoposide—germ cell cancer	0.000793	0.00268	CcSEcCtD
Atomoxetine—HTR2A—spinal cord—germ cell cancer	0.000792	0.0014	CbGeAlD
Atomoxetine—Anorexia—Etoposide—germ cell cancer	0.000782	0.00265	CcSEcCtD
Atomoxetine—Decreased appetite—Cisplatin—germ cell cancer	0.000779	0.00263	CcSEcCtD
Atomoxetine—Diarrhoea—Dactinomycin—germ cell cancer	0.000776	0.00262	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000773	0.00262	CcSEcCtD
Atomoxetine—Vomiting—Bleomycin—germ cell cancer	0.000773	0.00261	CcSEcCtD
Atomoxetine—Infestation—Methotrexate—germ cell cancer	0.000771	0.00261	CcSEcCtD
Atomoxetine—Infestation NOS—Methotrexate—germ cell cancer	0.000771	0.00261	CcSEcCtD
Atomoxetine—Depression—Methotrexate—germ cell cancer	0.000768	0.0026	CcSEcCtD
Atomoxetine—Rash—Bleomycin—germ cell cancer	0.000767	0.00259	CcSEcCtD
Atomoxetine—Pain—Cisplatin—germ cell cancer	0.000766	0.00259	CcSEcCtD
Atomoxetine—Dermatitis—Bleomycin—germ cell cancer	0.000766	0.00259	CcSEcCtD
Atomoxetine—Conjunctivitis—Methotrexate—germ cell cancer	0.000749	0.00253	CcSEcCtD
Atomoxetine—Asthenia—Ifosfamide—germ cell cancer	0.000745	0.00252	CcSEcCtD
Atomoxetine—Feeling abnormal—Cisplatin—germ cell cancer	0.000738	0.0025	CcSEcCtD
Atomoxetine—Paraesthesia—Etoposide—germ cell cancer	0.000737	0.00249	CcSEcCtD
Atomoxetine—Pruritus—Ifosfamide—germ cell cancer	0.000735	0.00249	CcSEcCtD
Atomoxetine—Somnolence—Etoposide—germ cell cancer	0.00073	0.00247	CcSEcCtD
Atomoxetine—Nausea—Bleomycin—germ cell cancer	0.000722	0.00244	CcSEcCtD
Atomoxetine—Vomiting—Dactinomycin—germ cell cancer	0.000721	0.00244	CcSEcCtD
Atomoxetine—Rash—Dactinomycin—germ cell cancer	0.000715	0.00242	CcSEcCtD
Atomoxetine—HTR2A—endocrine gland—germ cell cancer	0.000713	0.00126	CbGeAlD
Atomoxetine—Decreased appetite—Etoposide—germ cell cancer	0.000713	0.00241	CcSEcCtD
Atomoxetine—Diarrhoea—Ifosfamide—germ cell cancer	0.000711	0.0024	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000708	0.0024	CcSEcCtD
Atomoxetine—Body temperature increased—Cisplatin—germ cell cancer	0.000708	0.0024	CcSEcCtD
Atomoxetine—Fatigue—Etoposide—germ cell cancer	0.000708	0.00239	CcSEcCtD
Atomoxetine—HTR2A—head—germ cell cancer	0.000704	0.00125	CbGeAlD
Atomoxetine—Pain—Etoposide—germ cell cancer	0.000702	0.00237	CcSEcCtD
Atomoxetine—Constipation—Etoposide—germ cell cancer	0.000702	0.00237	CcSEcCtD
Atomoxetine—CYP2D6—female gonad—germ cell cancer	0.000699	0.00124	CbGeAlD
Atomoxetine—Dizziness—Ifosfamide—germ cell cancer	0.000687	0.00232	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000683	0.00231	CcSEcCtD
Atomoxetine—HTR2A—testis—germ cell cancer	0.00068	0.0012	CbGeAlD
Atomoxetine—Urethral disorder—Methotrexate—germ cell cancer	0.000678	0.00229	CcSEcCtD
Atomoxetine—Feeling abnormal—Etoposide—germ cell cancer	0.000676	0.00229	CcSEcCtD
Atomoxetine—Nausea—Dactinomycin—germ cell cancer	0.000674	0.00228	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000671	0.00227	CcSEcCtD
Atomoxetine—Vomiting—Ifosfamide—germ cell cancer	0.000661	0.00223	CcSEcCtD
Atomoxetine—CYP3A4—endocrine gland—germ cell cancer	0.00066	0.00117	CbGeAlD
Atomoxetine—Rash—Ifosfamide—germ cell cancer	0.000655	0.00222	CcSEcCtD
Atomoxetine—Dermatitis—Ifosfamide—germ cell cancer	0.000655	0.00221	CcSEcCtD
Atomoxetine—Urticaria—Etoposide—germ cell cancer	0.000652	0.00221	CcSEcCtD
Atomoxetine—CYP2D6—endocrine gland—germ cell cancer	0.00065	0.00115	CbGeAlD
Atomoxetine—Body temperature increased—Etoposide—germ cell cancer	0.000649	0.00219	CcSEcCtD
Atomoxetine—Abdominal pain—Etoposide—germ cell cancer	0.000649	0.00219	CcSEcCtD
Atomoxetine—Asthenia—Cisplatin—germ cell cancer	0.000643	0.00217	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—germ cell cancer	0.000642	0.00217	CcSEcCtD
Atomoxetine—CYP2D6—head—germ cell cancer	0.000642	0.00114	CbGeAlD
Atomoxetine—HTR2A—cerebellum—germ cell cancer	0.000628	0.00111	CbGeAlD
Atomoxetine—Angiopathy—Methotrexate—germ cell cancer	0.000628	0.00212	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000624	0.00211	CcSEcCtD
Atomoxetine—Chills—Methotrexate—germ cell cancer	0.000621	0.0021	CcSEcCtD
Atomoxetine—CYP2D6—testis—germ cell cancer	0.00062	0.0011	CbGeAlD
Atomoxetine—Nausea—Ifosfamide—germ cell cancer	0.000617	0.00209	CcSEcCtD
Atomoxetine—Diarrhoea—Cisplatin—germ cell cancer	0.000613	0.00207	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—germ cell cancer	0.000606	0.00205	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—germ cell cancer	0.000602	0.00204	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—germ cell cancer	0.00059	0.00199	CcSEcCtD
Atomoxetine—Asthenia—Etoposide—germ cell cancer	0.000589	0.00199	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—germ cell cancer	0.000583	0.00197	CcSEcCtD
Atomoxetine—Pruritus—Etoposide—germ cell cancer	0.000581	0.00196	CcSEcCtD
Atomoxetine—CYP2D6—cerebellum—germ cell cancer	0.000572	0.00101	CbGeAlD
Atomoxetine—Vomiting—Cisplatin—germ cell cancer	0.00057	0.00193	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—germ cell cancer	0.000568	0.00192	CcSEcCtD
Atomoxetine—Rash—Cisplatin—germ cell cancer	0.000565	0.00191	CcSEcCtD
Atomoxetine—Dermatitis—Cisplatin—germ cell cancer	0.000564	0.00191	CcSEcCtD
Atomoxetine—Diarrhoea—Etoposide—germ cell cancer	0.000561	0.0019	CcSEcCtD
Atomoxetine—Dizziness—Etoposide—germ cell cancer	0.000543	0.00184	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—germ cell cancer	0.000541	0.00183	CcSEcCtD
Atomoxetine—Nausea—Cisplatin—germ cell cancer	0.000532	0.0018	CcSEcCtD
Atomoxetine—Cough—Methotrexate—germ cell cancer	0.000526	0.00178	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—germ cell cancer	0.000522	0.00177	CcSEcCtD
Atomoxetine—Vomiting—Etoposide—germ cell cancer	0.000522	0.00176	CcSEcCtD
Atomoxetine—Rash—Etoposide—germ cell cancer	0.000517	0.00175	CcSEcCtD
Atomoxetine—Dermatitis—Etoposide—germ cell cancer	0.000517	0.00175	CcSEcCtD
Atomoxetine—Headache—Etoposide—germ cell cancer	0.000514	0.00174	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—germ cell cancer	0.000513	0.00173	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—germ cell cancer	0.000513	0.00173	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—germ cell cancer	0.000513	0.00173	CcSEcCtD
Atomoxetine—HTR2A—brain—germ cell cancer	0.00051	0.000904	CbGeAlD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000509	0.00172	CcSEcCtD
Atomoxetine—Infection—Methotrexate—germ cell cancer	0.000488	0.00165	CcSEcCtD
Atomoxetine—Nausea—Etoposide—germ cell cancer	0.000487	0.00165	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—germ cell cancer	0.000482	0.00163	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—germ cell cancer	0.000477	0.00161	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000475	0.00161	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—germ cell cancer	0.000469	0.00158	CcSEcCtD
Atomoxetine—CYP2D6—brain—germ cell cancer	0.000465	0.000823	CbGeAlD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000448	0.00151	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—germ cell cancer	0.000445	0.0015	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—germ cell cancer	0.000441	0.00149	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—germ cell cancer	0.000437	0.00148	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—germ cell cancer	0.000433	0.00146	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—germ cell cancer	0.000427	0.00145	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000424	0.00144	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—germ cell cancer	0.000424	0.00143	CcSEcCtD
Atomoxetine—Pain—Methotrexate—germ cell cancer	0.00042	0.00142	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—germ cell cancer	0.000405	0.00137	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000402	0.00136	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—germ cell cancer	0.00039	0.00132	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—germ cell cancer	0.000389	0.00131	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—germ cell cancer	0.000389	0.00131	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—germ cell cancer	0.000353	0.00119	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—germ cell cancer	0.000348	0.00118	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—germ cell cancer	0.000336	0.00114	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—germ cell cancer	0.000325	0.0011	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—germ cell cancer	0.000313	0.00106	CcSEcCtD
Atomoxetine—Rash—Methotrexate—germ cell cancer	0.00031	0.00105	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—germ cell cancer	0.00031	0.00105	CcSEcCtD
Atomoxetine—Headache—Methotrexate—germ cell cancer	0.000308	0.00104	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—germ cell cancer	0.000292	0.000988	CcSEcCtD
